Press Room

This article takes a look back on the evolution of PerkinElmer’s ICP-MS innovations for environmental testing over the past three decades up through the new NexION 5000.

As the second Lighthouse Lab brought online by PerkinElmer on behalf of the DHSC, the Charnwood Lighthouse Lab will increase its daily testing capacity to 50,000 by early 2021.

PerkinElmer has launched the newest ChemOffice+ Cloud application for chemistry communication workflows. This offering shifts the inefficient procedures to a new, intuitive cross-document search.

PerkinElmer hosted an exhibit at the Chinese International Import Expo (CIIE) where industry leaders could get an in-person look at our technologies including explorer™ workstations for SARS-CoV-2 testing.

EUROIMMUN, a PerkinElmer company, has launched the new ELISA assay to quantify IgG antibodies against the SARS-CoV-2 S1 antigen.

PerkinElmer has agreed to acquire Horizon Discovery, a company based in the UK that offers gene editing and gene modulation tools, to expand the portfolio of automated Life Sciences and Applied Genomics.

Carola Schmidt, Global Director of Automated Solutions at PerkinElmer, shared her insight about biobanking and how to ensure the integrity and security to standardize the procedure and implement best practices.

Innovative private-public partnership with PerkinElmer will soon allow California to process an additional 150,000 COVID-19 tests a day.

PerkinElmer’s COVID-19 Nucleic Acid Detection Kit is certified for sample pooling to allow a greater number of individuals to be tested without increasing resources.

With the flu season approaching, PerkinElmer has received CE-IVD for the PKamp Respiratory SARS-CoV-2 RT-PCR Panel that simultaneously tests COVID-19, the flu and RSV with only one sample.

PerkinElmer JANUS G3 automated liquid handlers and chemagic 360 closed loop extraction unit have helped Synergy Diagnostic Laboratory in delivering COVID-19 tests to increase the capacity to more than 1,000 tests per shift.

James Coffin, President and Chief Operating Officer, Sema4, talks about how PerkinElmer is providing best-in-class, highly accurate PCR tests (7:40 mark).

The National Center for Advancing Translational Sciences (NCATS) at National Institutes of Health (NIH) is using PerkinElmer’s AlphaLISA no-wash immunoassay to conduct drug compound screening as part of the search for drug repurposing candidates for COVID-19.

PerkinElmer supports BioMarin, a biopharmaceutical firm, for their sponsored testing program in Mexico to identify Batten disease and mucopolysaccharidosis (MPS) disorders.

PerkinElmer launched the industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow to detect pesticide residue in cannabis and hemp flower samples.

PerkinElmer helps ramp up testing at “Lighthouse Lab” for Public Health Wales. This aims to expand the capacity to 20,000 tests per day by the end of October.

Adding to the entire newborn screening solutions, PerkinElmer EONIS newborn screening assay simultaneously tests for SMA, SCID and ELA.

Gary Grecsek, Vice President/General Manager of Global OneSource Enterprise Laboratory Services and Tony Pezzolo, Product Manager of Validation, discuss how labs can stay in the know and ahead of the curve on compliance and data integrity challenges with the help of an external, expert compliance team.

Listeria carries a 20 – 30% mortality rate for those in high-risk categories so vigilant testing is important. The PerkinElmer Solus Listeria monocytogenes ELISA Assay tests both food and environmental samples and has been certified by the AOAC.

The FDA released comparative performance data for 58 COVID-19 test manufacturers. PerkinElmer’s detection kit that uses nasopharyngeal swabs in viral transport media topped the list.

Madhuri Hegde, Vice President and Chief Scientific Officer at PerkinElmer Genomics, shared how recent advancements in genomic sequencing technologies are enabling simultaneous rapid analysis for large amounts of genetic information, making it easier and faster to apply these learnings to clinical care.

Stefan Tordenmalm, Market Manager of Processed Food at PerkinElmer, highlights the most common types of food fraud reported by customers and how analytical chemistry helps to ensure food safety and quality.

Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN, helped us demystify the differences between the S and N proteins, whose presence indicates the immune response against COVID-19.

Though person-to-person transmission is the primary way of spreading COVID-19, environmental surfaces should also not be neglected. PerkinElmer’s environmental testing kits help detect the virus on surfaces such as plastic, ceramic, or stainless steel.

With COVID-19 continuing to spread and flu season on the way, methanol recalls in hand sanitizers are unwelcomed news. Helping to ensure the safety of these high-demand products, PerkinElmer launched the enhanced Hand Sanitizer Analyzer providing methanol pass/fail results in 30 seconds starting at 300 ppm.

PerkinElmer CEO Prahlad Singh joined Jim Cramer on CNBC’s Mad Money to discuss the how the company’s unique, comprehensive turnkey solutions help in the fight against COVID-19.

The new series of explorer^™ workstations for COVID-19 testing can prepare and run up to 10,000 COVID-19 tests daily. These modular and scalable workstations will increase testing capacity for quicker results.

Sonoma County aims to triple volume of coronavirus test processing with new technologyRachel Rees, director of the public health lab in Sonoma County, California, envisions the lab conducting 900 to 1,200 virus tests per day with PerkinElmer’s technology.

Arvind Kothandaraman, General Manager of Specialty Diagnostics at PerkinElmer, shares seven key factors that organizations should take into consideration when choosing a new COVID-19 testing workflow.

PerkinElmer is dedicated to providing labs with LC-MS software interface and analytical management platforms that are easy to use. Prof. Antonio D’Avolio at the University of Turin talks about how this technology is used to quantify remdesivir, the potential cure for COVID-19.

As global scientists work tirelessly to discover therapeutics and vaccines for COVID-19, there’s massive amounts of existing data that can be invaluable. PerkinElmer has introduced open COVID-19 Data Dashboards to help scientists easily access, analyze and gain insights from data sources.

With the harvest season approaching, PerkinElmer is launching the AuroFlow^® AQ Mycotoxin Platform to screen grain including corn and wheat. This new solution includes strip tests for various of mycotoxin contaminations.

Equipped with a modern user interface and simplified data connectivity, PerkinElmer’s Perten Glutomatic® 2000 System is designed to operate within automated process workflows.

In the part two of the Analytical Cannabis series, Toby Astill from PerkinElmer shared thoughts on topics like adulterant, stability and potency in regard to analyzing cannabis-infused products.

HCS is a powerful tool to help fight viral foes like COVID-19, Ebola, MERS and Zika. Dr. Karin Bottcher talks about how high content screening (HCS) has been used globally to help with drug discovery for repurposing existing drug candidates and creating new therapeutics and vaccines.

Compared with 2D cultures, more complex cultures that use primary cells and multiple cell types in three dimensions provide more physiologically-relevant data for use in target validation.

“FemTech” is a technology that addresses a variety of women’s health issues and according to Karen Madden, Ph.D., Vice President of Technology and Innovation at PerkinElmer, it is gaining more attention. She also shared insights into the Company's Vanadis non-invasive prenatal testing (NIPT) solutions.

Karen Madden, Ph.D., Vice President of Technology and Innovation at PerkinElmer, spoke with The Boston Globe to talk about the current trend and outlook of precision medicine.

With viral tests manufactured by PerkinElmer, Sema4, a Stamford-headquartered firm, has expanded its capacity to run about 15,000 COVID-19 tests per day.

In the first half of the Analytical Cannabis series, our expert Toby Astill discussed the product development and manufacturing of cannabis-based beverages.

PerkinElmer partners with Public Health Wales (PHW) to achieve the Welsh Government’s “Test, Trace, Protect” strategy by providing advanced extraction equipment and testing kits that meet the UK’s ongoing requirements.

With the new EURORealTime SARS-CoV-2 assay, PerkinElmer expands its COVID-19 comprehensive testing portfolio to three FDA EUA solutions.

PerkinElmer has announced the addition of the DELFIA Xpress sFlt-1 kit to its CE-IVD pre-eclampsia product offering to aid in diagnosis in the second and third trimesters of pregnancy.

eXXpedition the all-female microplastics research vessel has returned to dry land due to COVID-19 but continues gaining scientific insights using our FT-IR technology.

PerkinElmer LactoScope FT-B instrument offers rapid and accurate component testing and adulterant screening for dairy products. This instrument can be paired with other PerkinElmer platforms to achieve exhaustive performance.

Amidst COVID-19, PerkinElmer is ready to support our global customers with a wide range of solutions, including detection, workflow and research.

EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits are helping Beaumont Health as part of its research study demystify COVID-19 as the research expands to wider patient groups.

EUROIMMUN provides LabCorp with dried blood spot antibody tests to screen employers as their return-to-work plans.

PerkinElmer Solus One Salmonella, an assay that offers solutions to analyze select foods and delivers results within one day, obtained OMA from AOAC INTERNATIONAL, which is considered the highest level of AOAC certification.

After CE marked in Europe, PerkinElmer’s Anti-SARS-CoV-2 ELISA serological test receives Emergency Use Authorization (EUA) from the FDA.

PerkinElmer’s MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits offer same-day testing for all five targeted antibiotic residues in farmed shrimp with high accuracy.

Stefan Tordenmalm, Market Manager of Processed Food at PerkinElmer, shares his thoughts about the adulteration of olive oil, which is at high risk for food fraud. To ensure its quality, rapid testing techniques like infrared (IR) and UV-visible spectroscopy (UV-Vis) are crucial in protecting consumers./p>

PerkinElmer’s record for positive social and environmental impact is recognized in story on company’s efforts to expand COVID-19 testing in Texas.

Tailored for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, PerkinElmer’s new analysis and automation solutions are designed to help streamline workflows, sharpen insights and meet regulations.

To answer the need for wider COVID-19 testing in the US, EUROIMMUN, a PerkinElmer company, collaborates with Quest Diagnostics to detect immunoglobulin class G (IgG) antibodies. Quest is expected to boost testing to 150,000 a day by early May.

PerkinElmer EUROLabWorkstations and EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits designed to help Beaumont Health gain knowledge about disease transmission and whether COVID-19 antibodies offer protection after infection.

PerkinElmer’s instruments contribute to an antibody study at Beaumont Health, which could potentially identify those with immunity against COVID-19.

Alan Fletcher, vice president and GM, life sciences, shares insights about leveraging the potential of existing drugs to combat COVID-19.

As part of the donation from researchers at Augusta University and Georgia Tech, PerkinElmer’s products help with COVID-19 testing at the GEM lab of Medical College of Georgia.

PerkinElmer’s RT-PCR test assists in screening for COVID-19 at the Clinical and Translational Research Center, University at Buffalo. This effort helps combat COVID-19 in Erie County, NY.

PerkinElmer’s automated lab solutions support Rutgers' RUCDR Infinite Biologics, handling 10,000 nucleic acid extractions per day.

To support the diagnostics of COVID-19, the Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer company, is now CE marked in Europe.

PerkinElmer receives Emergency Use Authorization (EUA) from the FDA for the PT-PCR test for detection of COVID-19.

Dr. Stan Naides, the Director of Scientific Affairs at EUROIMMUN, a PerkinElmer company, shares his perspective on COVID-19, its progression and impact on laboratories and their personnel.

In this interview, Petra Furu, the General Manager of Reproductive Health at PerkinElmer, talks about the recently approved DMD screening kit and the promise of non-invasive testings.

Statistics show that women in China are more likely to be in senior leadership roles than many other Asian countries. Here Ms. Ye (Nicky) Xu, General Manager of Diagnostics at PerkinElmer Greater China shares her journey and some career, business and personal growth tips to help inspire the world’s women in science and healthcare.

PerkinElmer’s VICTOR EnLite Instrument and EnLite Neonatal TREC Kit will be available as part of a Severe Combined Immunodeficiency (SCID) evaluation program in collaboration with Public Health England.

When added with LPC 500^™ Liquid Particle Counter, PerkinElmer’s Avio^® 500 ICP-OES can analyze oils or lubricants for both wear metals and particles in one run. This costs less than 1 mL of sample and takes 45 seconds to provide accurate and stable results.

PerkinElmer launches top technologies at the Society for Laboratory Automation and Screening (SLAS) in San Diego. Highlighted products include JANUS^® G3 Blood iQ^™ Workstation, Sciclone^® G3 NGSx HT Workstation as well as Opera Phenix^® Plus High Content Screening System.

To ensure the safety of medicines, PerkinElmer offers pharma companies a comprehensive solution to detect N-nitrosodimethylamine (NDMA) impurity in ranitidine.

PerkinElmer’s liquid handling workstations facilitate sample tracking by incorporating automated barcode scanning into every step of sample processing.

Lead scientist of the eXXpedition research boat Dr. Winnie Courtene-Jones shares how the portable and powerful Spectrum Two FT/IR Spectrometer is being used on board to test for microplastics in our oceans.

As an AI-driven technology solution provider, PerkinElmer is enhancing researchers’ ability to analyze massive amounts of data in a timely fashion.

Together with PerkinElmer, New York State has screened the first infant for Duchenne as part Parent Project Muscular Dystrophy’s (PPMD's) Newborn Screening Pilot.

Cannabis and hemp labs need high quality, end-to-end testing and analysis solutions to keep up with growing demand and regulations. PerkinElmer is teaming up with Emerald Scientific to help.

With PerkinElmer’s spectrometer on board, the all-women research voyage is on the mission of identifying and documenting microplastics during the sails.

Duchenne Muscular Dystrophy is a rare genetic disorder and the most prevalent type of muscular dystrophy. The FDA has approved PerkinElmer’s GSP^® Neonatal Creatine Kinase-MM (CK-MM) kit for DMD screening.

ESPGHAN recently updated guidelines for the diagnosis of Celiac disease, which are expected to be more widespread and easy for both patients and gastroenterologists.

Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.

AI and machine learning can help pharmas repurpose failed clinical trial data to drive new breakthroughs and treatments. David Wang, Masha Hoffey and Dr. Simone Sharma discuss key considerations and best practices.

PerkinElmer's new MuviCyte live-cell imaging system helps researcher study cell behavior and function in new ways. Karin Boettcher weighs in on the importance of controlling environmental parameters with advanced innovation.

PerkinElmer offers high-throughput platforms for electrophoresis-based biomolecule separation, sizing, and quantitation.

Mycotoxin testing for grains is a key step in securing global food safety. PerkinElmer’s Mark McBeath discusses best practices and innovative solutions for analysis from strips to LC-MS/MS.

PerkinElmer Genomics will begin processing about 2,500 samples with the Vanadis non-invasive prenatal testing (NIPT) system in Pittsburgh and Kuala Lumpur.

In this article PerkinElmer’s Toby Astill and Aaron Hineman weigh in on the use of ICP-MS to tackle heavy metals testing in cannabis.

Rice is a mega-staple for global consumers and testing for rice quality is key. The newPaddyCheck testing platform speeds sample throughput, increases accuracy and allows for grain testing at the paddy stage whether in-field or in a lab.

PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment.

PerkinElmer is exploring the use of deep learning methods to improve analysis of image data from high content screening—in some cases, solving problems that conventional algorithms can’t.

Food safety is paramount. In this byline, PerkinElmer’s Greg Sears discusses advances in testing and analysis for everything from heavy metals, pesticides and mycotoxins, to foodborne pathogens and antibiotics.

A new clinical study further validates PerkinElmer’s Vanadis non-invasive prenatal testing (NIPT) system, which uses fully-automated imaging instead of DNA sequencing or PCR amplification.

Dr. Madhuri Hegde of PerkinElmer Genomics talks about the critical role that genetic counseling plays in consumer-initiated DNA testing today.

In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.

To battle food fraud, PerkinElmer’s Greg Sears and Stefan Tordenmalm explain how robust analytical and informatics solutions can detect and analyze adulterants throughout the supply chain.

Beachcombing in Spain drew PerkinElmer’s Ian Robertson into not only his main field of research but an endeavor that fuels debate on microplastics in bottled water.

Linh Hoang, PerkinElmer’s vice president of Reproductive Health, spoke with Bloomberg about molecular testing options available right now for screening newborns with SMA (spinal muscular atrophy).

Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.